Know what you really own

Unwrap both →

Fund comparison · from official SEC filings

BIB vs IDNA: how much do they overlap?

ProShares Ultra Nasdaq Biotechnology and iShares Genomics Immunology and Healthcare ETF

Fund A

vs

Fund B

Holdings overlap

14%

of assets, by weight

Shared positions

29

of 259 / 62 holdings

BIB expense ratio

0.95%

net, per year

IDNA expense ratio

0.47%

net, per year

Shared holdings

Company

BIB

IDNA

R

RVMDREVOLUTION MEDICINES INC

1.74%

5.70%

M

MRNAMODERNA INC

1.04%

5.22%

V

VRTXVERTEX PHARMACEUTICALS INC

5.18%

2.96%

R

REGNREGENERON PHARMACEUTICALS

3.57%

3.10%

B

BNTXBIONTECH SE-ADR

0.61%

3.39%

E

EXELEXELIXIS INC

0.73%

3.16%

T

TWSTTWIST BIOSCIENCE CORP

0.23%

3.15%

I

INCYINCYTE CORP

1.08%

2.93%

I

IDYAIDEAYA BIOSCIENCES INC

0.14%

2.25%

I

IBRXIMMUNITYBIO INC

0.43%

2.17%

C

CAICARIS LIFE SCIENCES INC

0.26%

2.03%

C

CRSPCRISPR THERAPEUTICS AG

0.30%

1.50%

N

NVAXNOVAVAX INC

0.10%

1.09%

I

IOVAIOVANCE BIOTHERAPEUTICS INC

0.09%

1.03%

V

VIRVIR BIOTECHNOLOGY INC

0.08%

0.89%

A

ABCLABCELLERA BIOLOGICS INC

0.10%

0.88%

C

CRVSCORVUS PHARMACEUTICALS INC

0.06%

0.80%

J

JANXJANUX THERAPEUTICS INC

0.05%

0.71%

K

KURAKURA ONCOLOGY INC

0.05%

0.69%

C

CTMXCYTOMX THERAPEUTICS INC

0.03%

0.50%

R

RIGLRIGEL PHARMACEUTICALS INC

0.03%

0.47%

N

NTLAINTELLIA THERAPEUTICS INC

0.09%

0.47%

P

PACBPACIFIC BIOSCIENCES OF CALIF

0.03%

0.40%

D

DSGNDESIGN THERAPEUTICS INC

0.03%

0.39%

A

ALVOALVOTECH SA

0.06%

0.33%

Only in BIB

?

—N/A

17.83%

I

IQMMPROSHARES GENIUS MNY MKT ETF

7.57%

G

GILDGILEAD SCIENCES INC

5.19%

A

AMGNAMGEN INC

4.99%

?

—Repurchase Agreement

3.50%

A

ALNYALNYLAM PHARMACEUTICALS INC

2.24%

B

BIIBBIOGEN INC

1.61%

I

ILMNILLUMINA INC

1.39%

U

UTHRUNITED THERAPEUTICS CORP

1.36%

R

RPRXROYALTY PHARMA PLC- CL A

1.34%

A

ARGXARGENX SE - ADR

1.33%

I

INSMINSMED INC

1.29%

R

ROIVROIVANT SCIENCES LTD

1.20%

V

VTRSVIATRIS INC

1.05%

G

GHGUARDANT HEALTH INC

0.95%

A

AGPXXINVESCO GVT & AGNCY-INST

0.90%

N

NBIXNEUROCRINE BIOSCIENCES INC

0.89%

J

JAZZJAZZ PHARMACEUTICALS PLC

0.81%

A

ASNDASCENDIS PHARMA A/S

0.77%

S

SMMTSUMMIT THERAPEUTICS INC

0.76%

B

BBIOBRIDGEBIO PHARMA INC

0.72%

M

MEDPMEDPACE HOLDINGS INC

0.71%

I

IONSIONIS PHARMACEUTICALS INC

0.71%

A

AXSMAXSOME THERAPEUTICS INC

0.67%

M

MDGLMADRIGAL PHARMACEUTICALS INC

0.64%

Only in IDNA

B

BISXXBCF INSTITUTIONAL-SL AGNCY

17.45%

I

IPSEFIPSEN

4.36%

B

BAYZFBAYER AG-REG

3.64%

T

TKPHFTAKEDA PHARMACEUTICAL CO LTD

3.51%

M

MRKMERCK & CO. INC.

3.45%

G

GLAXFGSK PLC

3.43%

R

RHHVFROCHE HOLDING AG

3.32%

S

SNYNFSANOFI

2.98%

G

GNMSFGENMAB A/S

2.63%

R

RCUSARCUS BIOSCIENCES INC

1.77%

O

OPHLFONO PHARMACEUTICAL CO LTD

1.55%

2

2595GENFLEET THERAPEUTICS SHAN-H

1.00%

N

NUVBNUVATION BIO INC

0.98%

6

6887SUNSHINE LAKE PHARMA CO LT-H

0.52%

O

OCGNOCUGEN INC

0.49%

1

174900ABCLON INC

0.47%

S

SGBCFSHANGHAI HENLIUS BIOTECH I-H

0.42%

I

INRLFVALNEVA SE

0.37%

D

DNAGINKGO BIOWORKS HOLDINGS INC

0.33%

V

VSTMVERASTEM INC

0.33%

2

2591GUANGZHOU INNOGEN PHARMACE-H

0.11%

?

—EURO

0.03%

M

MREOMEREO BIOPHARMA GROUP PL-ADR

0.03%

?

—GREAT BRITISH POUND

0.01%

?

—SWISS FRANC

0.00%

Hold BIB and IDNA together? See your combined true holdings, overlap, and blended fees — free, no signup.

Unwrap your portfolio →

Other comparisons you might like

BIB vs IBBQInvesco Nasdaq Biotechnology ETF

BIB vs IBBiShares Biotechnology ETF

BIB vs UWMProShares Ultra Russell2000

BIB vs URTYProShares UltraPro Russell2000

IDNA vs IBBiShares Biotechnology ETF

BIB vs VHTVANGUARD HEALTH CARE INDEX FUND

Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.

BIB vs IDNA: 14% holdings overlap — Unwrap.Fund